Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Programmed cell death in amyotrophic lateral sclerosis
Christelle Guégan, Serge Przedborski
Christelle Guégan, Serge Przedborski
Published January 15, 2003
Citation Information: J Clin Invest. 2003;111(2):153-161. https://doi.org/10.1172/JCI17610.
View: Text | PDF
Perspective Article has an altmetric score of 5

Programmed cell death in amyotrophic lateral sclerosis

  • Text
  • PDF
Abstract

Authors

Christelle Guégan, Serge Przedborski

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Illustrations of PCD alterations in spinal cord of transgenic mutant SOD...
Illustrations of PCD alterations in spinal cord of transgenic mutant SOD1 mice. (a) Photomicrograph of definitely apoptotic cells found in the anterior horn of an end-stage transgenic SOD1G93A mouse. The arrow shows several typical round chromatin clumps. (b) Western blot analysis of spinal cord extracts, demonstrating the relocation of Bax from the cytosol (top) to the mitochondria (bottom) over the course of the disease. (c) Coincidental changes of cytochrome c in the opposite direction. (d) Later in the disease, effector caspases such as caspase-7 are activated. 1M (AS): 1 month, asymptomatic stage; 2M (AS): 2 months, asymptomatic stage; 3M (BS): 3 months, beginning of symptoms; 5M (ES): 5 months, end stage; Non-TG: nontransgenic littermates. Modified from ref. 63.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
63 readers on Mendeley
See more details